Arbutus Biopharma Corp (ABUS)
NASDAQ·Healthcare·Biotechnology
$4.44
+1.83%
Mkt Cap $871.14M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
Implied Upside
+91.4%
Consensus $8.50 vs current $4.44
NASDAQ·Healthcare·Biotechnology
$4.44
+1.83%
Mkt Cap $871.14M
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
+91.4%
Consensus $8.50 vs current $4.44